Latest filing published 03 Jan 2024 for CYTOKINETICS INC, €11k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Sandford d. Smith across 2 companies, led by Cytokinetics Inc and Aegerion Pharmaceuticals, Inc. The record holds 21 filings, for trades running from 27 January 2016 to 2 January 2024.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 3 January 2024 came the latest disclosure, a share grant for €11k in Cytokinetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations